I think they were expecting for it to end but have decided to continue it further.
Sentiment: Strong Buy
The only news I see is that the panel recommended to continue the trial, so why would the CEO say on a cnbc interview that before the end of this year we will know if the data is good or not--a little confused
Jimmy Carter credits the new cancer drug Keytruda for shrinking his brain tumors completely. It's one more possible victory for the newest class of cancer drugs that empower the immune system to fight off tumors.
But cancer experts note that it's not at all clear that the drug itself is what shrank Carter's tumors. The former president was also treated with radiation to his brain and had a large tumor on his liver removed.
While most immune therapy drugs boost the immune system so that it can battle the cancer, Keytruda was the first drug to take a different approach that disrupts a trick tumors use to hide from immune cells.
Keytruda — known generically as pembrolizumab — targets the activity of genes called PD-1 and PD-L1. The interaction between the two genes lets some tumors escape detection and destruction by immune system cells.
“"It's as good of an outcome as someone with advanced melanoma can hope for."”
PD-1 stops immune cells from attacking normal healthy cells by mistake. Tumor cells make PD-L1 turn on PD-1 when immune cells approach. Keytruda, an engineered immune protein called a monoclonal antibody, disrupts this cloaking effect and lets the immune cells do their job and eat the tumor cell.
Carter's Sunday school class erupted in applause when he announced his latest checkup showed his tumors appear to have shrunk completely. "And when I went this week, they didn't find any cancer at all, so I have good news," he told his overflowing class.
It's unusual, but not unheard of. Carter has stage 4 melanoma, meaning it has spread around his body. It's almost never cured, but even stage 4 cancer can shrink so much that scans don't find it — for a while. It almost always comes back
Seems like maybe an official statement regarding President Carter and KEytruda could really give the stocksome momentum. From what i can tell, it seems that the company is shying away from taking the credit-just yet. Hopefully some conclusive evidence will come out saying indeed the drug was elemental to elimininating the tumor.
I watched the video on cnbc with the ceo of Merck, anyone know what he meant by "we'll know by the end of the year, if the results are good or not" what trial is he talking about--what data should we expect?
More like a sniper, focusing in on the cancer cell. Reported on national news Monday night. $150,000 for a year's supply. Will there be other products by others?
Half is a low expectation though not for the billions healed. Data this Friday will lend more guidance...
Sentiment: Strong Buy